OTOF基因突变致先天性聋患者基因治疗给药的临床协作技巧
Clinical collaboration techniques for gene therapy delivery in OTOF-related congenital deafness
左丹妮;罗章华;朱梦迪;吕俊;王会;舒易来;龚瑜
1:复旦大学附属眼耳鼻喉科医院护理部
2:复旦大学附属眼耳鼻喉科医院耳鼻喉科
摘要关键词基金项目(Foundation):作者参考文献[1] 王秋菊.新医学时代遗传性聋研究与应用[J].听力学及言语疾病杂志，2023,31(3):197-201.
[2] 吴皓，孙常领.感音神经性耳聋的基因治疗研究进展[J].中国听力语言康复科学杂志，2017,15(3):201-204.
[3] 王新兰，田海月，钟翠萍，等.基因与干细胞治疗感音神经性聋的研究现状[J].中华耳科学杂志，2020,18(2):404-408.
[4] CHRISTINA M S H,AMANDA O B,A ELIOT S,et al.Comprehensive genetic testing in the clinical evaluation of 1 119 patients with hearing loss[J].Hum Genet,2016,135(4):441-450.
[5] YOH-ICHIRO I,SHIN-YA N,AKIKO S,et al.OTOF mutation analysis with massively parallel DNA sequencing in 2 265 Japanese sensorineural hearing loss patients[J].PLoS One,2019,14(5):e0215932.
[6] LV J,WANG H,CHENG X,et al.AAV1-hOTOF gene therapy for autosomal recessive deafness 9:a single-arm trial[J].Lancet,2024,403(10441):2317-2325.
[7] WANG H,CHEN Y,LV J,et al.Bilateral gene therapy in children with autosomal recessive deafness 9:single-arm trial results[J].Nat Med,2024,30(7):1898-904.
[8] 钟佳珂，蒋罗颖，崔冲，等.OTOF基因突变听神经病的基因治疗临床试验与设计[J].听力学及言语疾病杂志，2025,33(1):1-7.
[9] CTCAE(V5.0).Common Terminology Criteria for Adverse Events[M]. Of Health And Human Services.2017.
[10] ZHANG L L,WANG J,GAO Z W,et al.A novel delivery approach of clinical inner ear gene therapy[J].Otol Neurotol,2024.DOI:10.1097/MAO.0000000000004366.
[11] 褚连军，童明琼，孙婉.耳部感染患者病原菌分布及药敏分析[J].中国病原生物学杂志，2022,17(10):1180-1183.
[12] 赵喜红，王武庆.内镜下潜水磨骨在上鼓室切开的应用[J].中华耳科学杂志，2020,18(1):190-194.
[13] 张莹，王菲，龚树生.耳科手术护理配合标准作业程序的构建与应用[J].护理学杂志，2019,34(20):16-19.
[14] 刘飞红，崔旭，王惠军，等.耳科手术中改变头位对可弯喉罩对位及通气的影响[J].北京医学，2019,41(8):664-666.